Skip to main content

Table 1 Laboratories with molecular diagnostics in surveyed regions

From: Gridlock from diagnosis to treatment of multidrug-resistant tuberculosis in Tanzania: low accessibility of molecular diagnostic services and lack of healthcare worker empowerment in 28 districts of 5 high burden TB regions with mixed methods evaluation

Characteristics Regions
All Dar es Salaam Mbeya Morogoro Mwanza Shinyanga
Laboratories with molecular diagnostics for MDR-TB diagnosis per District. No.(%) 11 (39) 5 (42) 2 (50) 1 (25) 1 (25) 2 (50)
Number of samples received for XpertMTB/RIF per day. No/ median (IQR) 12 (11–22) 20 (14–24) 11 (10–12) 12 (−) 10 (−) 21 (11–30)
Number of samples tested in XpertMTB/RIF per day. No/Median (IQR) 12 (12–14) 12 (12–16) 9 (6–12) 8 (−) 10 (−) 18 (12–24)
Number of staff for operating the XpertMTB/RIF per laboratory 3 (2–6) 3 (2–3) 7 (2–11) 2 (−) 5 (−) 9 (7–10)
Number of staff trained for operating the XpertMTB/RIF. No./Median (IQR) 3 (2–4) 3 (2–3) 2 (−) 3 (−) 2 (−) 4 (−)
Estimated months XpertMTB/RIF was not working due to several reasons 2 (1–4) 3 (2–5) 3 (1–4) 2 (−) 1 (−) 2 (1–2)